Nandrolone Phenylpropionate 100 mg/ml

Nandrolone Phenylpropionate 100 mg/ml — Swiss Remedies

• Brand: Swiss Remedies
• Category: Injectable AAS · 19-nortestosterone derivative
• Content: 100 mg/ml NPP
• Packaging: 10 1 ml ampoules (100 mg per ampoule)
• Total content: 1,000 mg nandrolone phenylpropionate
• Origin: Switzerland
• Note: For laboratory and analytical research only. Not for human or veterinary use.

Product Overview

Nandrolone Phenylpropionate (NPP) is the short-acting ester of nandrolone, providing a rapid rise and relatively fast decline in serum levels after intramuscular administration.

It is widely used as a reference anabolic agent in research exploring muscle hypertrophy, bone remodeling, connective-tissue recovery, and the endocrine and cardiometabolic effects of AAS exposure.

Because of its short ester, NPP allows fine-tuned dosing windows and is preferred when tight pharmacokinetic control is required.

Nandrolone and its esters are WADA S1-prohibited anabolic agents.

Key Research Highlights

• Model anabolic compound: Frequently used in hypertrophy and nitrogen-balance studies.
• 19-nor derivative: Removal of carbon-19 methyl group alters AR affinity and metabolism.
• Short-ester kinetics: Faster onset and shorter duration than nandrolone decanoate.
• Connective tissue interest: Studied for effects on collagen output, tendon/ligament repair, and joint integrity.
• Systemic research: Used to explore gonadotropin suppression, lipid changes, and cardiovascular markers.

Mechanism of Action

• Androgen receptor activation: Nandrolone binds ARs in muscle, bone, and connective tissue, modulating anabolic gene networks.
• Enhanced protein synthesis: Supports amino-acid incorporation and positive nitrogen balance.
• Bone and collagen effects: Promotes osteoblastic activity and may increase collagen synthesis in research models.
• Hormonal interactions: Mild aromatization to estrogen; potential impact on prolactin signalling.

Potential Research Applications

• Lean mass & strength studies: Muscle fibre size, recovery, and anti-catabolic effects.
• Bone density research: Osteoporosis and fracture-healing investigations.
• Joint/cartilage & connective tissue: Tendon and ligament recovery, collagen analysis.
• Endocrine suppression models: LH/FSH reduction, testosterone suppression, recovery timelines.
• Cardiometabolic safety: Lipid markers, blood pressure, haematocrit dynamics.

Side Effects & Research Risk Indicators

• Endocrine suppression: Strong inhibition of LH/FSH and natural testosterone production.
• Cardiovascular strain: Reduced HDL, increased LDL, possible BP elevation.
• Estrogenic/prolactin effects: Water retention, BP changes, gynaecomastia risk.
• Androgenic impacts: Acne, body hair changes, androgenic alopecia; virilisation in females.
• Systemic effects: Mood changes, altered liver enzymes, injection-site irritation.

Compliance & Anti-Doping Notice

Nandrolone and all nandrolone esters are banned at all times by the World Anti-Doping Agency (WADA S1).

Detection windows for nandrolone metabolites can be prolonged, especially in frequent-dose or long-term exposure models.

Legal status: In most countries, nandrolone is a prescription-controlled medicine.

Unauthorised handling or human administration may be illegal.

Research-only disclaimer:

This product is supplied strictly for laboratory, forensic, and analytical research.

It is NOT a dietary supplement or performance-enhancing product for human or animal use.

Technical Specifications

Storage

Cool, dry, protected from light; do not freeze

Use Category

Anabolic-androgenic steroid · Research-only reference standard